Back
Results - Announcements
Sales reported at Rs 0.20 crore
Venmax Drugs & Pharmaceuticals reports standalone net loss of Rs 0.50 crore in the December 2024 quarter
08-Feb-2025, 05:32
Net loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.50 crore in the quarter ended December 2024 as against net profit of Rs 0.03 crore during the previous quarter ended December 2023. Sales reported to Rs 0.20 crore in the quarter ended December 2024. There were no Sales reported during the previous quarter ended December 2023.
Net loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.50 crore in the quarter ended December 2024 as against net profit of Rs 0.03 crore during the previous quarter ended December 2023. Sales reported to Rs 0.20 crore in the quarter ended December 2024. There were no Sales reported during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 0.20 | 0 | 0 |
| OPM % | -250.00 | 0 | - |
| PBDT | -0.50 | 0.04 | PL |
| PBT | -0.50 | 0.04 | PL |
| NP | -0.50 | 0.03 | PL |
Powered by Capital Market - Live News